N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 2973-2979

  Kurie, Jonathan M ^a   Lee, Jin S ^a   Khuri, Fadlo R ^a   Mao, Li ^a   Morice, Rodolfo C ^a   Lee, J Jack ^a   Walsh, Garrett L ^a   Broxson, Anita ^a   Lippman, Scott M ^a   Ro, Jae Y ^a   Kemp, Bonnie L ^a   Liu, Diane ^a   Fritsche, Herbert A ^a   Xu, Xiaochun ^a   Lotan, Reuben ^a   Hong, Waun K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; RETINOIC ACID RECEPTOR; RETINOID;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; LUNG CANCER; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL METAPLASIA;

ADULT; AGED; ANTICARCINOGENIC AGENTS; BIOPSY; BRONCHI; BRONCHOSCOPY; EPITHELIUM; FEMALE; FENRETINIDE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; SMOKING;

EID: 0033875561     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Strong, M. S., Incze, J., and Vaughan, C. W. Field cancerization in the aerodigestive tract - its etiology, manifestation, and significance. J. Otolaryngol., 12: 1-6, 1984.
2. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Firket, P., Rosmertz, N., Clerici, M., Soresi, E., Valerte, M., et al. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J. Clin. Oncol., 11: 1216-1222, 1993.
3. Benner, S. E., Lippman, S. M., and Hong, W. K. Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res., 52: 2758s-2763s, 1992.
4. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., and Peters, L. J. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
5. Lee, J. S., Lippman, S. M., Benner, S. E., Lee, J. J., Ro, J. Y., Lukeman, J. M., et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J. Clin. Oncol., 12: 937-945, 1994.
6. Xu, X. C., Lee, J. S., Morice, R. C., Liu, X., Lippman, S. M., Lee, J. J., Hong, W. K., and Lotan, R. Nuclear retinoic acid receptor β in bronchial epithelium of smokers before and during chemoprevention. J. Natl. Cancer Inst., 91: 1317-1321, 1999.
7. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. B. Roberts, D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, Ed. 2. New York: Raven Press, Ltd., 1994.
8. Kim, Y. H., Dohi, D., Han, G. R., Zou, C. P., Oridate, N., Walsh, G. L., et al. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
9. Geradts, J., Chen, J. Y., Russell, E. K., Yankaskas, J. R., Nieves, L., and Minna, J. D. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ., 4: 799-809, 1993.
10. Moghal, N., and Neel, B. G. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol., 15: 3945-3959, 1995.
11. Dmitrovsky, E. N-(4-hydroxphenyl)retinamide activation of a distinct pathway signaling apoptosis. J. Natl. Cancer Inst., 89: 1179-1181, 1997.
12. Formelli, F., Barua, A. B., and Olson, J. A. Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl β-glucuronide. FASEB J., 10: 1014-1024, 1996.
13. Kalemkerian, G. P., Slusher, R., Ramalingam, S., Gadgeel, S., and Mabry, M. Growth inhibition and induction of apoptosis by fenretinide in small cell lung cancer. J. Natl. Cancer Inst., 87: 1674-1680, 1995.
14. Zou, C-P., Kurie, J., Lotan, D., Zou, C-C., Hong, W. K., and Lotan, R. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Clin. Cancer Res., 4: 1345-1355, 1998.
15. Lotan, R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst., 87: 1655-1657, 1995.
16. MacCrehan, W. A. NIST measurements of (4-hydroxyphenyl)retinamide in serum. Clin. Chem., 33: 1585-1592, 1987.
17. Hansen, L. G., and Warwick, W. J. A fluorometric micromethod for serum vitamin A. Am. J. Clin. Pathol., 50: 525-529, 1968.
18. Xu, X. C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K., and Lotan, R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res., 54: 3580-3587, 1994.
19. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
20. Agresti, A. An Introduction to Categorical Data Analysis. New York: John Wiley and Sons, Inc., 1996.
21. Armitage, P., and David, H. A. (eds.). Advances in Biometry. New York: John Wiley and Sons, Inc., 1996.
22. Formelli, F., Carsana, R., Costa, A., Buranelli, F., Campa, T., Dossena, G., Magni, A., and Pizzichetta, M. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one-year follow-up study of breast cancer patients. Cancer Res., 49: 6149-6152, 1989.
23. Lam, S., MacAulay, C., Hung, J., LeRiche, J., Profio, A. E., and Palcic, B. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J. Thorac. Cardiovasc. Surg., 105: 1035-1040, 1993.
24. Lam, S., MacAulay, C., and Palcic, B. Detection and localization of early lung cancer by imaging techniques. Chest, 103(Suppl. 1): 12S-14S, 1993.
25. Auerbach, O., Stout, A. P., Hammond, E. C., and Garfinkel, L. Changes in bronchial epithelium in relation to sex, age, residence, smoking and pneumonia. N. Engl. J. Med., 267: 111-119, 1962.
26. Kurie, J. M., Shin, H. J. C., Lee, J. S., Morice, R. C., Ro, J. Y., Lippman, S. M., Hittelman, W. N., Yu, R., Lee, J.-J., and Hong, W. K. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin. Cancer Res., 2: 1787-1793, 1996.
27. Kazmi, S. M., Plante, R. K., Visconti, V., and Lau, C. Y. Comparison of N-(4-hydroxphenyl)retinamide and all-trans retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res., 56: 1056-1062, 1996.
28. Fanjul, A. N., Delia, D., Pierotti, M. A., Rideout, D., Qiu, J., and Pfahl, M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem., 271: 22441-22446, 1996.
29. Clifford, J. L., Menter, D. G., Wang, M., Lotan, R., and Lippman, S. M. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res., 59: 14-18, 1999.
30. Kitareewan, S., Spinella, M. J., Allopenna, J., Reczek, P. R., and Dmitrovsky, E. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RAR-γ independent pathway. Oncogene, 18: 5747-5755, 1999.
31. Oridate, N., Suzuki, S., Masahiro, H., Mitchell, M., Hong, W. K., and Lotan, R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J. Natl. Cancer Inst., 89: 1191-1198, 1997.
32. Oridate, N., Lotan, D., Xu, X. C., Hong W. K., and Lotan, R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
33. Mariani, L., Formelli, F., De Palo, G., Manzari, A., Camerini, T., Campa, T., DiMauro, M. G., Crippa, A., Delle Grottaglie, M., Del Vecchio, M., Marubini, E., Costa, A., and Veronesi, U. Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerabilty. Tumori, 82: 444-449, 1996.
34. Caruso, R. C., Zujewski, J., Iwata, F., Podgor, M. J., Conley, B. A., Ayres, L. M., and Kaiser-Kupfer, M. I. Effects of fenretinide (4-HPR) on dark adaptation. Arch. Ophthalmol., 116: 759-763, 1998.
35. Holven, K. B., Natarajan, V., Gundersen, T. E., Moskaug, J. O., Norum, K. R., and Blomhoff, R. Secretion of N-(4-hydroxyphenyl)retinamide-retinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretin. Int. J. Cancer, 71: 654-659, 1997.
36. Malpeli, G., Folli, C., and Berni, R. Retinoid binding to retinolbinding protein and the interference with the interaction with transthyretin. Biochim. Biophys. Acta, 1294: 48-54, 1996.
37. Chopra, D. P., Cooney, R. A., and Taylor, G. W. Effects of vitamin A deficiency on cell proliferation and morphology of trachea of the hamster. Cell Tissue Kinet., 23: 575-586, 1990.
38. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskers, F. L., Valaris, B., Williams, J. A., Barnhart, S., and Hammar, S. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 334: 1150-1155, 1996.
39. Heinonen, O. P., and Albanes, D. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 330: 1029-1081, 1994.
40. Veronesi, U., De Palo, G., Marubini, E., Costa, A., Formelli, F., Mariani, L., Decensi, A., Camerini, T., Del Turco, M. R., Di Mauro, M. G., Muraca, M. G., Del Vecchio, M., Pinto, C., D'Aiuto, G., Boni, C., Campa, T., Magni, A., Miceli, R., Perloff, M., Malone, W. F., and Sporn, M. B. Randomized trial of fenretinide to prevent second primary breast malignancy in women with early breast cancer. J. Natl. Cancer Inst., 91: 1847-1856, 1999.
41. Lippman, S. M., Lee, J. J., and Sabichi, A. L. Cancer chemoprevention: Progress and promise. J. Natl. Cancer Inst., 90: 1514-1528, 1998.